COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY

Bibliographic Details
Main Author: ROSÁRIO,DAVI ARAÚJO VEIGA
Publication Date: 2021
Other Authors: FALEIRO,THIAGO BATISTA, FRANCO,BRUNO ADELMO FERREIRA MENDES, DALTRO,GILDÁSIO DE CERQUEIRA, MARCHETTO,REINALDO
Format: Article
Language: eng
Source: Acta Ortopédica Brasileira (Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-78522021000100026
Summary: ABSTRACT Objective: To compare bone marrow aspirate concentrate (BMAC) with the standard treatment for gluteal tendinopathies. Methods: 48 patients diagnosed with gluteal tendinopathy at a university hospital were selected by a randomized clinical trial and divided into two groups: (G1) bone marrow aspirate concentrate and (G2) corticosteroid injections. Results: 40 of the 48 selected patients were monitored for six months and both groups showed better scores. Visual analog scale (VAS) scores and Lequesne index were statistically significant higher in patients submitted to BMAC treatment when compared to standard treatment. Both groups improved their quality of life, without statistically significant difference. Conclusion: BMAC constitutes an alternative to gluteal tendinopathy standard treatment, proving to be a safe technique with promising results when combined with multidisciplinary team behavioral therapy. Level of Evidence II, Randomized Clinical Trial.
id SBOT-1_3a290d86674b34481394746391ac3215
oai_identifier_str oai:scielo:S1413-78522021000100026
network_acronym_str SBOT-1
network_name_str Acta Ortopédica Brasileira (Online)
repository_id_str
spelling COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHYTendinopathyBone Marrow CellsHip JointAdrenal Cortex HormonesABSTRACT Objective: To compare bone marrow aspirate concentrate (BMAC) with the standard treatment for gluteal tendinopathies. Methods: 48 patients diagnosed with gluteal tendinopathy at a university hospital were selected by a randomized clinical trial and divided into two groups: (G1) bone marrow aspirate concentrate and (G2) corticosteroid injections. Results: 40 of the 48 selected patients were monitored for six months and both groups showed better scores. Visual analog scale (VAS) scores and Lequesne index were statistically significant higher in patients submitted to BMAC treatment when compared to standard treatment. Both groups improved their quality of life, without statistically significant difference. Conclusion: BMAC constitutes an alternative to gluteal tendinopathy standard treatment, proving to be a safe technique with promising results when combined with multidisciplinary team behavioral therapy. Level of Evidence II, Randomized Clinical Trial.ATHA EDITORA2021-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-78522021000100026Acta Ortopédica Brasileira v.29 n.1 2021reponame:Acta Ortopédica Brasileira (Online)instname:Sociedade Brasileira de Ortopedia e Traumatologia (SBOT)instacron:SBOT10.1590/1413-785220212901236828info:eu-repo/semantics/openAccessROSÁRIO,DAVI ARAÚJO VEIGAFALEIRO,THIAGO BATISTAFRANCO,BRUNO ADELMO FERREIRA MENDESDALTRO,GILDÁSIO DE CERQUEIRAMARCHETTO,REINALDOeng2021-03-08T00:00:00Zoai:scielo:S1413-78522021000100026Revistahttp://www.actaortopedica.com.br/https://old.scielo.br/oai/scielo-oai.php1atha@uol.com.br||actaortopedicabrasileira@uol.com.br1809-44061413-7852opendoar:2021-03-08T00:00Acta Ortopédica Brasileira (Online) - Sociedade Brasileira de Ortopedia e Traumatologia (SBOT)false
dc.title.none.fl_str_mv COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
title COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
spellingShingle COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
ROSÁRIO,DAVI ARAÚJO VEIGA
Tendinopathy
Bone Marrow Cells
Hip Joint
Adrenal Cortex Hormones
title_short COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
title_full COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
title_fullStr COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
title_full_unstemmed COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
title_sort COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY
author ROSÁRIO,DAVI ARAÚJO VEIGA
author_facet ROSÁRIO,DAVI ARAÚJO VEIGA
FALEIRO,THIAGO BATISTA
FRANCO,BRUNO ADELMO FERREIRA MENDES
DALTRO,GILDÁSIO DE CERQUEIRA
MARCHETTO,REINALDO
author_role author
author2 FALEIRO,THIAGO BATISTA
FRANCO,BRUNO ADELMO FERREIRA MENDES
DALTRO,GILDÁSIO DE CERQUEIRA
MARCHETTO,REINALDO
author2_role author
author
author
author
dc.contributor.author.fl_str_mv ROSÁRIO,DAVI ARAÚJO VEIGA
FALEIRO,THIAGO BATISTA
FRANCO,BRUNO ADELMO FERREIRA MENDES
DALTRO,GILDÁSIO DE CERQUEIRA
MARCHETTO,REINALDO
dc.subject.por.fl_str_mv Tendinopathy
Bone Marrow Cells
Hip Joint
Adrenal Cortex Hormones
topic Tendinopathy
Bone Marrow Cells
Hip Joint
Adrenal Cortex Hormones
description ABSTRACT Objective: To compare bone marrow aspirate concentrate (BMAC) with the standard treatment for gluteal tendinopathies. Methods: 48 patients diagnosed with gluteal tendinopathy at a university hospital were selected by a randomized clinical trial and divided into two groups: (G1) bone marrow aspirate concentrate and (G2) corticosteroid injections. Results: 40 of the 48 selected patients were monitored for six months and both groups showed better scores. Visual analog scale (VAS) scores and Lequesne index were statistically significant higher in patients submitted to BMAC treatment when compared to standard treatment. Both groups improved their quality of life, without statistically significant difference. Conclusion: BMAC constitutes an alternative to gluteal tendinopathy standard treatment, proving to be a safe technique with promising results when combined with multidisciplinary team behavioral therapy. Level of Evidence II, Randomized Clinical Trial.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-78522021000100026
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-78522021000100026
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1413-785220212901236828
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv ATHA EDITORA
publisher.none.fl_str_mv ATHA EDITORA
dc.source.none.fl_str_mv Acta Ortopédica Brasileira v.29 n.1 2021
reponame:Acta Ortopédica Brasileira (Online)
instname:Sociedade Brasileira de Ortopedia e Traumatologia (SBOT)
instacron:SBOT
instname_str Sociedade Brasileira de Ortopedia e Traumatologia (SBOT)
instacron_str SBOT
institution SBOT
reponame_str Acta Ortopédica Brasileira (Online)
collection Acta Ortopédica Brasileira (Online)
repository.name.fl_str_mv Acta Ortopédica Brasileira (Online) - Sociedade Brasileira de Ortopedia e Traumatologia (SBOT)
repository.mail.fl_str_mv 1atha@uol.com.br||actaortopedicabrasileira@uol.com.br
_version_ 1752122276870881280